Jiexia Ding
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biochemistry top 10%
- Sulfur Compounds in Biology
Papers in
-
- Liver Disease Diagnosis and Treatment 7
-
- Peroxisome Proliferator-Activated Receptors 1
- Co-authors
- Xingyong Wan (2 shared papers)Chaohui Yu (3 shared papers)Youming Li (4 shared papers)Xi Jin (2 shared papers)Shaohua Chen (1 shared paper)Meng Li (1 shared paper)Youming Li (2 shared papers)Panpan Cen (5 shared papers)
In The Last Decade
Jiexia Ding
16 papers receiving 566 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 152
- Biochemistry 70
- Epidemiology 232
- Microbiology 5
- Hepatology 36
Countries citing papers authored by Jiexia Ding
This map shows the geographic impact of Jiexia Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiexia Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiexia Ding more than expected).
Fields of papers citing papers by Jiexia Ding
This network shows the impact of papers produced by Jiexia Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiexia Ding. The network helps show where Jiexia Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiexia Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 227 | |
| 2 | 2017 | 138 | |
| 3 | 2001 | 49 | |
| 4 | 2018 | 40 | |
| 5 | 2013 | 30 | |
| 6 | 2022 | 15 | |
| 7 | 2021 | 14 | |
| 8 | 2022 | 13 | |
| 9 | 2017 | 11 | |
| 10 | 2021 | 10 | |
| 11 | 2022 | 10 | |
| 12 | 2020 | 6 | |
| 13 | 2020 | 5 | |
| 14 | 2018 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2016 | 1 | |
| 17 | 2025 | 0 |
About Jiexia Ding
Jiexia Ding is a scholar working on Epidemiology, Molecular Biology, Pathology and Forensic Medicine, Pharmacology and Surgery, having authored 17 papers that have together received 571 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), Advanced Proteomics Techniques and Applications (1 paper), Sinusitis and nasal conditions (1 paper), Nasolacrimal Duct Obstruction Treatments (1 paper) and Gallbladder and Bile Duct Disorders (1 paper). The work is most often cited by research in Cancer Research (152 citations), Biochemistry (70 citations), Epidemiology (232 citations), Microbiology (5 citations) and Hepatology (36 citations). Jiexia Ding has collaborated with scholars based in China and Canada. Frequent co-authors include Xingyong Wan, Chaohui Yu, Youming Li, Xi Jin, Shaohua Chen, Meng Li, Youming Li, Panpan Cen, Chengfu Xu and Junping Shi. Their work appears in journals such as Molecular Biology Reports, PLoS ONE, Gastroenterology, Chemico-Biological Interactions and Influenza and Other Respiratory Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.